CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez
Nice, Alpes-Maritimes, 06001, France
NCT Number: NCT01087216
The treatment of vitiligo remains disappointing especially in some localization such as bony prominences and extremities. The association of UVB and topical steroids has been proven to be synergistic but the results are still insufficient in those difficult to treat areas. Promising results have been shown with the combination of laser assisted dermabrasion, topical 5FU and UVB. The investigators hypothesize that the dermabrasion of vitiligo skin followed by topical steroids should potentialized the effect of UVB and be superior to topical steroids and UVB without dermabrasion.
The main objective of this study is to evaluate the usefulness of laser assisted dermabrasion combined to topical steroids and UVB phototherapy in difficult to treat areas.
Patients with symmetrical non segmental vitiligo will be included in this prospective randomized monocentrer study. The investigators calculated the number of patients needed at 25. The side that will receive the dermabrasion will be centrally randomized and the opposite side will serve as control. Then on both side class 3 topical steroids will be applied daily 3 weeks on 4 for 12 weeks. UVB phototherapy will be performed twice weekly also for 12 weeks.
The evaluation will be performed by two independent physician blinded to the treatment of standardized photos before and 1 month after the end of the treatment. The criteria of success will be at least 75% of repigmentation.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Phase 2 / Phase 3
Nice, Alpes-Maritimes, 06001, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Opposite side lesions that will receive only the treatment by topical steroids and UVB phototherapy
patient to accept habitual treatment of corticoid Opposite side lesions that will receive only the treatment by topical steroids
Time frame: 4 months
Opposite side lesions that will received only the treatment by topical steroids and UVB phototherapy
Centre Hospitalier Universitaire de Nice
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00696358
Hypopigmentation, Pigmentation Disorders
Nice, France
View Trial DetailsNCT04822584
Hypopigmentation, Pigmentation Disorders
Bordeaux, France
View Trial DetailsNCT07181187
Hypopigmentation, Pigmentation Disorders
Hangzhou, Zhejiang, China
View Trial DetailsNCT04237103
Hypopigmentation, Pigmentation Disorders
Bordeaux, France
View Trial Details